Cytrellis Biosystems launches updated minimally invasive, in-office device for skin aging
Click Here to Manage Email Alerts
Key takeaways:
- The ellacor 2.0 system uses micro-coring technology to improve the appearance of sagging skin and wrinkles.
- The updated system reduces the procedure time and healing downtime by 35% and 60%, respectively.
Cytrellis Biosystems has launched an updated version of its minimally invasive, in-office device that treats the signs of skin aging, the company announced in a press release.
Following a limited release of the original ellacor device in 2022, the company has now launched ellacor 2.0 with updates that cut the procedure time by 35%, reduce downtime for healing by 60% and provide a simpler technique.
“ellacor fills a gap in the marketplace,” Denise Dajles, MSc, PhD, president and CEO of Cytrellis Biosystems, told Healio. “Eighty percent of physicians are underwhelmed with current energy-based devices due to limited efficacy, pain and long downtime. ellacor offers something different as it is the only permanent solution with no surgery, no thermal injury and no scarring.”
Improvements to the system that produced ellacor 2.0 were inspired by a company-wide collaboration with 250 clinicians. After conducting over 10,000 procedures with the device, the clinicians gave their feedback on how to improve the system, update protocols and make it easier to use.
“As a result, we have a simpler procedure technique with improved consistency of results,” Dajles added.
Cleared by the FDA in 2021, the ellacor system, which is designed for patients aged at least 22 years, uses the company’s micro-coring technology to remove sagging skin, treat wrinkles and rejuvenate the skin. Micro-coring technology uses hollow needles to remove the skin’s surface so that the skin can begin the natural process of self-healing.